NasdaqGS - Delayed Quote USD

Tempus AI, Inc (TEM)

Compare
51.40
-3.44
(-6.27%)
At close: January 24 at 4:00:00 PM EST
51.88
+0.48
+(0.93%)
After hours: 7:59:53 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
640,442.00
531,822.00
320,668.00
257,853.00
188,004.00
Cost of Revenue
299,845.00
245,647.00
190,482.00
174,209.00
159,290.00
Gross Profit
340,597.00
286,175.00
130,186.00
83,644.00
28,714.00
Operating Expense
1,033,274.00
482,258.00
395,628.00
327,355.00
222,168.00
Operating Income
-692,677.00
-196,083.00
-265,442.00
-243,711.00
-193,454.00
Net Non Operating Interest Income Expense
-44,643.00
-39,268.00
-18,862.00
-14,561.00
-17,434.00
Other Income Expense
-3,908.00
21,822.00
-4,846.00
-316.00
-466.00
Pretax Income
-741,228.00
-213,529.00
-289,150.00
-258,588.00
-211,354.00
Tax Provision
358.00
288.00
66.00
--
--
Earnings from Equity Interest Net of Tax
-1,692.00
-301.00
-595.00
-604.00
1,500.00
Net Income Common Stockholders
-800,706.00
-265,964.00
-333,928.00
-297,736.00
-253,905.00
Diluted NI Available to Com Stockholders
-800,706.00
-265,964.00
-333,928.00
-297,736.00
-253,905.00
Basic EPS
-5.16
-4.64
-2.09
-1.85
-1.58
Diluted EPS
-5.16
-4.64
-2.09
-1.85
-1.58
Basic Average Shares
155,178.69
159,882.00
159,882.00
160,708.00
160,708.00
Diluted Average Shares
155,178.69
159,882.00
159,882.00
160,708.00
160,708.00
Total Operating Income as Reported
-692,677.00
-196,083.00
-265,442.00
-243,711.00
-193,454.00
Total Expenses
1,333,119.00
727,905.00
586,110.00
501,564.00
381,458.00
Net Income from Continuing & Discontinued Operation
-743,278.00
-214,118.00
-289,811.00
-259,192.00
-209,854.00
Normalized Income
-743,278.00
-214,118.00
-289,811.00
-259,192.00
-209,854.00
Interest Income
9,275.00
7,601.00
3,032.00
623.00
1,495.00
Interest Expense
53,918.00
46,869.00
21,894.00
15,184.00
18,929.00
Net Interest Income
-44,643.00
-39,268.00
-18,862.00
-14,561.00
-17,434.00
EBIT
-687,310.00
-166,660.00
-267,256.00
-243,404.00
-192,425.00
EBITDA
-650,982.00
-133,328.00
-236,846.00
-219,523.00
-169,373.00
Reconciled Cost of Revenue
299,845.00
245,647.00
190,482.00
174,209.00
159,290.00
Reconciled Depreciation
36,328.00
33,332.00
30,410.00
23,881.00
23,052.00
Net Income from Continuing Operation Net Minority Interest
-743,278.00
-214,118.00
-289,811.00
-259,192.00
-209,854.00
Normalized EBITDA
-650,982.00
-133,328.00
-236,846.00
-219,523.00
-169,373.00
Tax Rate for Calcs
0.00
0.00
0.00
--
--
12/31/2020 - 6/14/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TDOC Teladoc Health, Inc.
10.09
-0.49%
 
ACON Aclarion, Inc.
0.0549
+27.08%
 
SDGR Schrödinger, Inc.
24.67
+1.07%
 
WGS GeneDx Holdings Corp.
79.27
+2.07%
 
VEEV Veeva Systems Inc.
223.40
+0.19%
 
GEHC GE HealthCare Technologies Inc.
88.67
+0.58%
 
TXG 10x Genomics, Inc.
14.81
-0.60%
 
FOXO FOXO Technologies Inc.
0.2734
+2.59%
 
BTSG BrightSpring Health Services, Inc.
22.82
+5.89%
 
BFRG Bullfrog AI Holdings, Inc.
2.4000
-7.69%